LUMORA LIMITEDActive
Key figures
LUMORA LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2023/24–2024/25
| 2023/24 | 2024/25 | |
|---|---|---|
| Turnover | 3,717,710 | — |
| Profit for the year | -243,767 | -270,666 |
| Cash at bank and in hand | 321,344 | 2,063 |
| Total assets | 648,265 | 253,664 |
| Total liabilities | — | 181,419 |
| Net assets / total equity | 342,911 | 72,245 |
| Average number of employees | 21 | 12 |
| Average pay (per year) | 82,778 | 73,874 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The company's principal activity was the research and development of clinical diagnostic tests.
As described in the company's latest filed accounts.
Summary: LUMORA LIMITED
Company
LUMORA LIMITED is a private limited company registered with Companies House under company number 04569106. It was incorporated on 22 Oct 2002. Its status is active. The registered office is in Uxbridge (UB9). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files full accounts. Loss for the year was £270,666. Net assets were £72,245, down 78.9% on the previous year. Cash at bank and in hand was £2,063. Total assets were £253,664 and total liabilities £181,419. The company had an average of 12 employees. Figures are available for 2 financial years (2023/24–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 7 Jul 2027.